Balance Sheet

Current Liabilities	78m
Accounts Payable	9.5m
Accrued Liabilities	68.5m
Non-Current Liabilities	45m
Other Non-Current Liabilities	45m

Currency: USD

	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	31	40	218	77	79	507	294	218	127
Cash Equivalents	31	40	218	77	79	507	294	218	127
Short-Term Investments	0	139	188	387	336	963	572	1 118	907
Total Receivables	0	0	1	1	0	6	1	0	0
Accounts Receivables	0	0	1	1	0	0	0	0	0
Other Receivables	0	0	0	0	0	0	0	0	0
Other Current Assets	3	3	3	15	15	20	31	36	30
Total Current Assets	33	182	410	481	430	1 496	897	1 372	1 064
PP&E Net	3	15	15	25	81	74	70	75	72
PP&E Gross	3	15	15	25	81	74	70	75	72
Accumulated Depreciation	0	2	5	12	12	21	29	37	46
Long-Term Investments	0	73	61	148	40	33	425	0	0
Other Long-Term Assets	0	1	1	8	3	3	12	13	18
Total Assets	37 N/A	271 +639%	487 +80%	662 +36%	553 -16%	1 604 +190%	1 404 -12%	1 460 +4%	1 154 -21%
Liabilities
Accounts Payable	2	2	3	2	3	1	5	3	9
Accrued Liabilities	2	6	11	19	24	47	53	67	68
Short-Term Debt	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	1	1	12	19	24	320	294	0
Total Current Liabilities	4	9	14	33	45	72	378	364	78
Long-Term Debt	0	0	0	0	0	0	0	0	0
Other Liabilities	1	7	7	82	113	382	64	54	45
Total Liabilities	4 N/A	17 +313%	21 +27%	115 +451%	158 +38%	454 +187%	442 -3%	418 -5%	123 -71%
Equity
Common Stock	49	349	1	1	1	2	2	2	2
Retained Earnings	17	104	192	228	426	354	645	971	1 116
Additional Paid In Capital	1	9	657	774	819	1 504	1 608	2 019	2 145
Other Equity	0	0	0	1	0	0	3	7	1
Total Equity	33 N/A	255 +678%	466 +83%	547 +17%	395 -28%	1 151 +191%	962 -16%	1 042 +8%	1 031 -1%
Total Liabilities & Equity	37 N/A	271 +639%	487 +80%	662 +36%	553 -16%	1 604 +190%	1 404 -12%	1 460 +4%	1 154 -21%
Shares Outstanding
Common Shares Outstanding	82	82	88	95	96	121	122	136	138

Denali Therapeutics Inc
NASDAQ:DNLI